michigan semaglutide ileus class action Tampa Bay residents among those alleging Ozempic caused stomach paralysis Weight Loss Drugs Lawsuit |

Risk of bias: all four RCTs were rated low risk by RoB2 (with some concerns for open-label outcome ascertainment in three trials, a domain-specific issue that does not alter the overall RoB2 category from low)

Schedule a consultation to learn more.

If Phase 3 data hold up, it becomes less about modality disruption and more about competitive differentiation inside the SM class

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo.

To compare the effects of semaglutide 1.0mg versus dulaglutide 3.0 and 4.5mg on HbA1c and body weight in patients with type 2 diabetes